Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Indivior (NASDAQ: INDV) will participate in the Piper Sandler 37th Annual Healthcare Conference in New York City on December 2, 2025. Chief Executive Officer Joe Ciaffoni and Chief Financial Officer Ryan Preblick will host 1x1 and group meetings and will join a fireside discussion at 3:30 p.m. ET on the same day. Interested investors should contact their Piper Sandler representative to schedule meetings. The fireside discussion will be publicly available via the Piper Sandler Fireside Chat Live Webcast.
Details
News Market Reaction – INDV
On Nov 19, the day this news came out, INDV closed 1.05% above the previous close.
Data tracked by StockTitan Argus for the Nov 19 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
-
Piper Sandler 37th Annual Healthcare Conference –
New York City , NY
Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2nd. Joe Ciaffoni and Ryan Preblick will also participate in a fireside discussion on Tuesday, December 2nd at 3:30 p.m.U.S. EST. Interested investors should contact their Piper Sandler representative to schedule a meeting.
The fireside discussion will be publicly available and can be viewed using the following weblink: Piper Sandler Fireside Chat Live Webcast.
About Indivior
Indivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visit
www.indivior.com
to learn more. Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/Indivior.
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302620339.html
SOURCE Indivior PLC
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.